Animal Vaccine Market Projected to Reach USD 33.41 Billion by 2033, Driven by Rising Pet Ownership and Livestock Immunization - Straits Research

According to a recent report by Straits Research, the global animal vaccine market was valued at USD 14.76 billion in 2024 and is projected to grow to USD 16.16 billion in 2025, ultimately reaching USD 33.41 billion by 2033. This represents a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2025 to 2033.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/animal-vaccine-market/request-sample

Understanding Animal Vaccination

Animal vaccination involves immunizing domestic, livestock, or wild animals against infectious diseases. These vaccines stimulate the immune system without causing the actual disease, ensuring that animals can develop immunity and respond effectively to pathogens. Beyond improving animal health, vaccines reduce financial losses for animal owners, lower antibiotic use, and mitigate the risk of drug-resistant microorganisms. They are crucial for both animal and public health, helping prevent zoonotic disease transmission and ensuring the safety and productivity of food animals.

Market Drivers: Rising Pet Ownership and Disease Prevalence

One of the key growth drivers of the animal vaccine market is the global rise in companion animal ownership. Pets significantly improve human quality of life, and families increasingly view them as integral members of the household. Countries like Australia and India have seen significant increases in pet populations, fueled by higher disposable incomes and growing public awareness of animal health, which has driven demand for veterinary vaccines.

Another major driver is the increasing prevalence of animal diseases. Infectious diseases like canine distemper in pets, and foot-and-mouth disease (FMD) and contagious bovine pleuropneumonia (CBPP) in livestock, are raising the demand for effective vaccines to protect both animals and human livelihoods.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/animal-vaccine-market/

Market Restraints: Adverse Reactions and Human Health Concerns

Despite the market's growth, certain factors are expected to impede expansion. Post-vaccination reactions such as anaphylaxis, autoimmune hemolytic anemia, and respiratory disease can increase veterinary expenses and concern among animal owners. Additionally, certain vaccine administration methods can increase human exposure to pathogens, making some pet owners hesitant to vaccinate their animals.

Opportunities: Plant-Based Veterinary Vaccines

The development of plant-based vaccines represents a significant opportunity in the market. Plants can act as production centers for subunit vaccines, offering reduced production costs-10 to 50 times lower than microbial or mammalian systems-while also minimizing contamination risks. This innovation is anticipated to further expand the animal vaccine market globally.

Regional Insights

North America is projected to dominate the market with a share of USD 5,349 million at a CAGR of 5%, driven by advanced veterinary infrastructure, high pet ownership, and technological advancements in vaccine development, particularly rabies vaccines. Europe is expected to be the second-largest market, reaching USD 4,638 million by 2030 with a CAGR of 5.7%, due to strong research initiatives, high adoption of companion animals, and stringent veterinary regulations.

The Asia-Pacific market is anticipated to grow rapidly, supported by government initiatives, increasing livestock populations, and growing investments in R&D to commercialize veterinary vaccines at affordable prices. For instance, India's cattle population reached 192.5 million in 2019, highlighting the significant need for livestock immunization.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/animal-vaccine-market/request-sample

Segment Analysis

By vaccine type, attenuated vaccines are expected to dominate the market, valued at USD 5,261 million, due to their strong and long-lasting immunity, fewer booster requirements, and potential to induce herd immunity. Recombinant vaccines are also anticipated to grow significantly, offering enhanced stability, multi-strain protection, and reduced need for adjuvants.

By animal type, livestock vaccines are expected to hold the largest market share of USD 9,865 million, while companion animal vaccines are projected to grow the fastest due to increasing awareness and the need for disease prevention in pets.

Key Market Players

Anicon Labor GmbH
Boehringer Ingelheim GmbH
Ceva Sante Animale
Hygieia Biological Laboratories
Merck & Co., Inc
Romvac Company S.A.

Browse More Insights & Reports

Bovine Serum Market : https://straitsresearch.com/report/bovine-serum-market

Aquaculture Vaccines Market : https://straitsresearch.com/report/aquaculture-vaccines-market

Encephalitis Vaccines Market : https://straitsresearch.com/report/encephalitis-vaccines-market

Gene Synthesis Market : https://straitsresearch.com/report/gene-synthesis-market

Contact Us

Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.

+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.

This release was published on openPR.